Related Experiment Video
Updated: Aug 15, 2026

Assaying Protein Kinase Activity with Radiolabeled ATP
Published on: May 26, 2017
Dominant-negative regulation of WNK1 by its kidney-specific kinase-defective isoform
Arohan R Subramanya1, Chao-Ling Yang, Xiaoman Zhu
1Division of Nephrology and Hypertension, Oregon Health and Science University, PP262, 3314 SW US Veterans Hospital Road, Portland, OR 97239, USA.
Abstract:
With-no-lysine kinase-1 (WNK1) gene mutations cause familial hyperkalemic hypertension (FHHt), a Mendelian disorder of excessive renal Na+ and K+ retention. Through its catalytic activity, full-length kinase-sufficient WNK1 (L-WNK1) suppresses its paralog, WNK4, thereby upregulating thiazide-sensitive Na-Cl cotransporter (NCC) activity. The predominant renal WNK1 isoform, KS-WNK1, expressed exclusively and at high levels in distal nephron, is a shorter kinase-defective product; the function of KS-WNK1 must therefore be kinase independent. Here, we report a novel role for KS-WNK1 as a dominant-negative regulator of L-WNK1. Na+ transport studies in Xenopus laevis oocytes demonstrate that KS-WNK1 downregulates NCC activity indirectly, by inhibiting L-WNK1. KS-WNK1 also associates with L-WNK1 in protein complexes in oocytes and attenuates L-WNK1 kinase activity in vitro. These observations suggest that KS-WNK1 plays an essential role in the renal molecular switch regulating Na+ and K+ balance; they provide insight into the kidney-specific phenotype of FHHt.
Insights
A shorter form of the With-no-lysine kinase-1 (WNK1) protein, KS-WNK1, acts as a dominant-negative regulator of the full-length L-WNK1 protein. This interaction is crucial for regulating sodium and potassium balance in the kidneys.
Area of Science:
- Nephrology
- Molecular Biology
- Genetics
Background:
- Mutations in the With-no-lysine kinase-1 (WNK1) gene cause familial hyperkalemic hypertension (FHHt), characterized by renal sodium (Na+) and potassium (K+) retention.
- Full-length, kinase-sufficient WNK1 (L-WNK1) normally suppresses WNK4, enhancing thiazide-sensitive Na-Cl cotransporter (NCC) activity.
Purpose of the Study:
- To investigate the function of the predominant renal WNK1 isoform, KS-WNK1, a shorter, kinase-defective product.
- To elucidate the role of KS-WNK1 in regulating L-WNK1 activity and its impact on renal Na+ and K+ balance.
Main Methods:
- Sodium transport studies were conducted using Xenopus laevis oocytes.
- Protein-protein interactions between KS-WNK1 and L-WNK1 were assessed.
- In vitro kinase assays were performed to evaluate the effect of KS-WNK1 on L-WNK1 kinase activity.
Main Results:
- KS-WNK1 was found to downregulate NCC activity indirectly by inhibiting L-WNK1.
- KS-WNK1 physically associates with L-WNK1 in protein complexes within oocytes.
- KS-WNK1 attenuates the kinase activity of L-WNK1 in vitro.
Conclusions:
- KS-WNK1 functions as a dominant-negative regulator of L-WNK1, independent of its own kinase activity.
- This interaction suggests a critical role for KS-WNK1 in the renal molecular switch controlling Na+ and K+ homeostasis.
- The findings provide insight into the kidney-specific mechanisms underlying FHHt.
Related Concept Videos
Canonical Wnt Signaling Pathway
Non-Canonical Wnt Signaling Pathways
Nephrons
The JAK-STAT Signaling Pathway
Negative Regulator Molecules
PI3K/mTOR/AKT Signaling Pathway